714 related articles for article (PubMed ID: 28819535)
21. ANA negative (Ro) lupus erythematosus with multiple major organ involvement: a case report.
Maraina CH; Kamaliah MD; Ishak M
Asian Pac J Allergy Immunol; 2002 Dec; 20(4):279-82. PubMed ID: 12744629
[TBL] [Abstract][Full Text] [Related]
22. Clinical manifestations, immunological features and prognosis of Chinese pediatric systemic lupus erythematosus: A single-center study.
Zhang CX; Cai L; Zhou ZY; Mao YY; Huang H; Yin L; Chen TX; Zhou W
Int J Rheum Dis; 2019 Jun; 22(6):1070-1076. PubMed ID: 30957986
[TBL] [Abstract][Full Text] [Related]
23. The outcome of patients with renal involvement in pediatric-onset systemic lupus erythematosus--a 20-year experience in Asia.
Lee PY; Yeh KW; Yao TC; Lee WI; Lin YJ; Huang JL
Lupus; 2013 Dec; 22(14):1534-40. PubMed ID: 23966304
[TBL] [Abstract][Full Text] [Related]
24. Effect of Autoantibodies to Erythropoietin Receptor in Systemic Lupus Erythematosus with Biopsy-proven Lupus Nephritis.
Hara A; Furuichi K; Yamahana J; Yasuda H; Iwata Y; Sakai N; Shimizu M; Kaneko S; Wada T
J Rheumatol; 2016 Jul; 43(7):1328-34. PubMed ID: 27134248
[TBL] [Abstract][Full Text] [Related]
25. Cross-reactivity of human lupus anti-DNA antibodies with alpha-actinin and nephritogenic potential.
Zhao Z; Weinstein E; Tuzova M; Davidson A; Mundel P; Marambio P; Putterman C
Arthritis Rheum; 2005 Feb; 52(2):522-30. PubMed ID: 15693007
[TBL] [Abstract][Full Text] [Related]
26. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
[TBL] [Abstract][Full Text] [Related]
27. Anti-dsDNA, anti-Sm antibodies, and the lupus anticoagulant: significant factors associated with lupus nephritis.
Alba P; Bento L; Cuadrado MJ; Karim Y; Tungekar MF; Abbs I; Khamashta MA; D'Cruz D; Hughes GR
Ann Rheum Dis; 2003 Jun; 62(6):556-60. PubMed ID: 12759294
[TBL] [Abstract][Full Text] [Related]
28. Clinical Significance of Anti-Ribosomal P Protein Antibodies in Patients with Lupus Nephritis.
Sarfaraz S; Anis S; Ahmed E; Muzaffar R
Rev Recent Clin Trials; 2018; 13(4):281-286. PubMed ID: 29629666
[TBL] [Abstract][Full Text] [Related]
29. [Laboratory and morphologic parameters in patients with lupus nephritis].
Rasković S; Bogić M; Perić-Popadić A; Stefanović L; Arandjelović S; Jovicić Z; Bolpacić J; Tomić-Spirić V
Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():38-41. PubMed ID: 12583312
[TBL] [Abstract][Full Text] [Related]
30. Clinical features and histological patterns of lupus nephritis in a single center of South India.
Devadass CW; Mysorekar VV; Eshwarappa M; Mekala L; Siddaiah MG; Channabasappa KG
Saudi J Kidney Dis Transpl; 2016; 27(6):1224-1230. PubMed ID: 27900970
[TBL] [Abstract][Full Text] [Related]
31. A cross-sectional hospital-based study of autoantibody profile and clinical manifestations of systemic lupus erythematosus in south Indian patients.
Kosaraju K; Shenoy S; Suchithra U
Indian J Med Microbiol; 2010; 28(3):245-7. PubMed ID: 20644315
[TBL] [Abstract][Full Text] [Related]
32. Sudanese and Swedish patients with systemic lupus erythematosus: immunological and clinical comparisons.
Elbagir S; Elshafie AI; Elagib EM; Mohammed NA; Aledrissy MIE; Sohrabian A; Nur MAM; Svenungsson E; Gunnarsson I; Rönnelid J
Rheumatology (Oxford); 2020 May; 59(5):968-978. PubMed ID: 31411331
[TBL] [Abstract][Full Text] [Related]
33. Simultaneous detection of anti-C1q and anti-double stranded DNA autoantibodies in lupus nephritis: predictive value for renal flares.
Matrat A; Veysseyre-Balter C; Trolliet P; Villar E; Dijoud F; Bienvenu J; Fabien N
Lupus; 2011 Jan; 20(1):28-34. PubMed ID: 20943718
[TBL] [Abstract][Full Text] [Related]
34. Frequency of class III and IV nephritis in systemic lupus erythematosus without clinical renal involvement: an analysis of predictive measures.
Wakasugi D; Gono T; Kawaguchi Y; Hara M; Koseki Y; Katsumata Y; Hanaoka M; Yamanaka H
J Rheumatol; 2012 Jan; 39(1):79-85. PubMed ID: 22089455
[TBL] [Abstract][Full Text] [Related]
35. An antibody profile of systemic lupus erythematosus detected by antigen microarray.
Fattal I; Shental N; Mevorach D; Anaya JM; Livneh A; Langevitz P; Zandman-Goddard G; Pauzner R; Lerner M; Blank M; Hincapie ME; Gafter U; Naparstek Y; Shoenfeld Y; Domany E; Cohen IR
Immunology; 2010 Jul; 130(3):337-43. PubMed ID: 20201986
[TBL] [Abstract][Full Text] [Related]
36. [Clinical and morphological characteristics of lupus nephritis in systemic lupus erythematosus with antiphospholipid syndrome].
Kozlovskaia NL; Shilov EM; Meteleva NA; Varshavskiĭ VA; Miroshnichenko NG; Samokishina NA; Serova AG; Nesterova SG
Ter Arkh; 2006; 78(5):21-31. PubMed ID: 16889045
[TBL] [Abstract][Full Text] [Related]
37. Systemic lupus erythematosus in Tunisia: demographic and clinical analysis of 100 patients.
Houman MH; Smiti-Khanfir M; Ben Ghorbell I; Miled M
Lupus; 2004; 13(3):204-11. PubMed ID: 15119551
[TBL] [Abstract][Full Text] [Related]
38. Simultaneous positivity for anti-DNA, anti-nucleosome and anti-histone antibodies is a marker for more severe lupus nephritis.
Sui M; Lin Q; Xu Z; Han X; Xie R; Jia X; Guo X; Zhang W; Guan X; Ren H
J Clin Immunol; 2013 Feb; 33(2):378-87. PubMed ID: 23100145
[TBL] [Abstract][Full Text] [Related]
39. Autoantibodies persist in relatives to systemic lupus erythematosus patients during 12 years follow-up.
Langkilde H; Voss A; Heegaard N; Laustrup H
Lupus; 2017 Jun; 26(7):723-728. PubMed ID: 27831535
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of antinucleosome antibodies by enzyme-linked immunosorbent assays in patients with systemic lupus erythematosus and other autoimmune systemic diseases.
Půtová I; Dostal C; Becvar R
Ann N Y Acad Sci; 2007 Aug; 1109():275-86. PubMed ID: 17785316
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
